DHR Danaher Stock Outlook 2026: Bioprocessing Recovery and the Return of the DBS Engine
Danaher stock analysis for 2026: bioprocessing destocking cycle resolution, Cytiva and Pall recovery thesis, Abcam acquisition integration, Cepheid post-pandemic diagnostic growth, Danaher Business System advantage, and valuation framework for the recovery story.
DHR Danaher Bioprocessing
